{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:03:19Z","timestamp":1792627399254,"version":"4.5.0"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T00:00:00Z","timestamp":1394582400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0091516","type":"journal-article","created":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T20:45:26Z","timestamp":1394657126000},"page":"e91516","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":135,"title":["A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model"],"prefix":"10.1371","volume":"9","author":[{"given":"Karen R.","family":"Buttigieg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart D.","family":"Dowall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Findlay-Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Miloszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Hewson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles W.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,12]]},"reference":[{"key":"ref1","unstructured":"Chumakov MP (1945) A new tick borne disease \u2013 Crimean hemorrhagic fever. In: Sokolov AA, Chumakov MP, Kolachev, editors. Crimean hemorrhagic fever (acute infectious capillary toxicosis). Simferopol: Izd. Otd. Primorskoi Armii. pp. 13\u201343."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3181\/00379727-131-33847","article-title":"Antigenic similarity between the virus causing Crimean hemorrhagic fever and Congo virus","volume":"131","author":"J Casals","year":"1969","journal-title":"Proc Soc Exp Biol Med"},{"key":"ref3","first-page":"1","article-title":"Management of patients with suspected viral hemorrhagic fever","volume":"37","year":"1988","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1473-3099(06)70435-2","article-title":"Crimean-Congo haemorrhagic fever","volume":"6","author":"O Ergonul","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"S794","DOI":"10.1093\/clinids\/11.Supplement_4.S794","article-title":"The clinical pathology of Crimean-Congo hemorrhagic fever","volume":"11","author":"R Swanepoel","year":"1989","journal-title":"Rev Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0166-3542(04)00163-9","article-title":"Crimean-Congo hemorrhagic fever","volume":"64","author":"CA Whitehouse","year":"2004","journal-title":"Antiviral Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"19504","DOI":"10.2807\/ese.15.10.19504-en","article-title":"Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness","volume":"15","author":"HC Maltezou","year":"2010","journal-title":"Euro Surveill"},{"key":"ref8","volume":"17","unstructured":"Atkinson B, Latham J, Chamberlain J, Logue C, O&apos;Donoghue L, <etal>et al<\/etal>.. (2012) Sequencing and phylogenetic characterisation of a fatal Crimean - Congo haemorrhagic fever case imported into the United Kingdom, October 2012. Euro Surveill <volume>17<\/volume>.."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0166-3542(93)90040-P","article-title":"Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection","volume":"22","author":"GH Tignor","year":"1993","journal-title":"Antiviral Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1099\/vir.0.019034-0","article-title":"Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice","volume":"91","author":"S Bereczky","year":"2010","journal-title":"J Gen Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1093\/infdis\/jit061","article-title":"Lethal Crimean-Congo hemorrhagic fever virus infection in interferon alpha\/beta receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy","volume":"207","author":"M Zivcec","year":"2013","journal-title":"J Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"11089","DOI":"10.1128\/JVI.01383-10","article-title":"Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model","volume":"84","author":"DA Bente","year":"2010","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1016\/j.vaccine.2012.08.003","article-title":"Healthy individuals&apos; immune response to the Bulgarian Crimean-Congo hemorrhagic fever virus vaccine","volume":"30","author":"M Mousavi-Jazi","year":"2012","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.1128\/JVI.76.14.7263-7275.2002","article-title":"Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus","volume":"76","author":"AJ Sanchez","year":"2002","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"8640","DOI":"10.1128\/JVI.77.16.8640-8649.2003","article-title":"Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1","volume":"77","author":"MJ Vincent","year":"2003","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"13271","DOI":"10.1128\/JVI.01647-07","article-title":"Crimean-Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1\/S1P is critical for virus infectivity","volume":"81","author":"E Bergeron","year":"2007","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1128\/JVI.79.10.6152-6161.2005","article-title":"Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins","volume":"79","author":"A Bertolotti-Ciarlet","year":"2005","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbrc.2011.06.109","article-title":"Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor","volume":"411","author":"X Xiao","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.vaccine.2005.08.034","article-title":"Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus","volume":"24","author":"K Spik","year":"2006","journal-title":"Vaccine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1128\/CVI.05352-11","article-title":"Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus","volume":"18","author":"SM Ghiasi","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0378-1119(83)90163-4","article-title":"Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA","volume":"25","author":"GL Smith","year":"1983","journal-title":"Gene"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/421266","article-title":"Modified vaccinia Ankara: potential as an alternative smallpox vaccine","volume":"38","author":"LH McCurdy","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1016\/j.vaccine.2013.03.021","article-title":"Recombinant MVA vaccines: dispelling the myths","volume":"31","author":"MG Cottingham","year":"2013","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.vaccine.2013.05.091","article-title":"Utilizing poxviral vectored vaccines for antibody induction-progress and prospects","volume":"31","author":"SJ Draper","year":"2013","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2240","article-title":"Viruses as vaccine vectors for infectious diseases and cancer","volume":"8","author":"SJ Draper","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Earl PL, Cooper N, Wyatt LS, Moss B, Carroll MW (1998) Preparation of Cell Cultures and Vaccinia Virus stocks. Curr Protoc Protein Sci Supp. 13: 5.12.11\u201315.12.12.","DOI":"10.1002\/0471140864.ps0512s13"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1517\/17460441.2.4.571","article-title":"Gateway recombinational cloning: a biological operating system","volume":"2","author":"F Katzen","year":"2007","journal-title":"Expert Opin Drug Discov"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1099\/0022-1317-73-3-653","article-title":"Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen","volume":"73 (Pt 3)","author":"T Hanke","year":"1992","journal-title":"J Gen Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1073\/pnas.0401939101","article-title":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice","volume":"101","author":"H Bisht","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Earl PL, Moss B, Wyatt LS, Carroll MW (1998) Generation of Recombinant Vaccinia Viruses. Curr Protoc Protein Sci Supp. 13: 5.13.11\u201315.13.19.","DOI":"10.1002\/0471140864.ps0513s13"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"UK Laemmli","year":"1970","journal-title":"Nature"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1089\/vbz.2011.0770","article-title":"Development of a real-time RT-PCR assay for the detection of Crimean-Congo hemorrhagic fever virus","volume":"12","author":"B Atkinson","year":"2012","journal-title":"Vector Borne Zoonotic Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0264-410X(96)00072-2","article-title":"Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model","volume":"14","author":"LS Wyatt","year":"1996","journal-title":"Vaccine"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72 (Pt 5)","author":"H Meyer","year":"1991","journal-title":"J Gen Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1099\/vir.0.83156-0","article-title":"Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara","volume":"88","author":"C Meisinger-Henschel","year":"2007","journal-title":"J Gen Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1016\/j.vaccine.2006.05.025","article-title":"Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge","volume":"24","author":"J Vipond","year":"2006","journal-title":"Vaccine"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jviromet.2008.08.011","article-title":"Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice","volume":"154","author":"M Luo","year":"2008","journal-title":"J Virol Methods"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1128\/JVI.02730-06","article-title":"Identification of a novel C-terminal cleavage of Crimean-Congo hemorrhagic fever virus PreG<sub>N<\/sub> that leads to generation of an NSM protein","volume":"81","author":"LA Altamura","year":"2007","journal-title":"J Virol"},{"key":"ref39","first-page":"2386","article-title":"[MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author&apos;s transl)]","volume":"99","author":"H Stickl","year":"1974","journal-title":"Dtsch Med Wochenschr"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"19ra12","DOI":"10.1126\/scitranslmed.3000490","article-title":"Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass","volume":"2","author":"R Alcock","year":"2010","journal-title":"Sci Transl Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1086\/590185","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa","volume":"198","author":"T Hawkridge","year":"2008","journal-title":"J Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4161\/hv.6.1.10116","article-title":"Prime-boost vectored malaria vaccines: progress and prospects","volume":"6","author":"AV Hill","year":"2010","journal-title":"Hum Vaccin"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1016\/j.vaccine.2011.08.098","article-title":"Safety and immunogenicity of a modified pox vector-based HIV\/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)","volume":"29","author":"F Garcia","year":"2011","journal-title":"Vaccine"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1158\/1078-0432.CCR-10-2082","article-title":"Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III study","volume":"16","author":"RJ Amato","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e62778","DOI":"10.1371\/journal.pone.0062778","article-title":"Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine","volume":"8","author":"TJ Powell","year":"2013","journal-title":"PLoS One"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1586\/14760584.2013.845531","article-title":"Clinical applications of attenuated MVA poxvirus strain","volume":"12","author":"CE Gomez","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4161\/hv.21689","article-title":"Therapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccines","volume":"8","author":"H Boukhebza","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1146\/annurev-immunol-032712-095916","article-title":"Broadly neutralizing antiviral antibodies","volume":"31","author":"D Corti","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/JVI.80.1.514-525.2006","article-title":"Crimean-congo hemorrhagic fever virus glycoprotein precursor is cleaved by Furin-like and SKI-1 proteases to generate a novel 38-kilodalton glycoprotein","volume":"80","author":"AJ Sanchez","year":"2006","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1743-422X-2-42","article-title":"Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins","volume":"2","author":"S Haferkamp","year":"2005","journal-title":"Virol J"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1099\/vir.0.81175-0","article-title":"Presence of broadly reactive and group-specific neutralizing epitopes on newly described isolates of Crimean-Congo hemorrhagic fever virus","volume":"86","author":"AA Ahmed","year":"2005","journal-title":"J Gen Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.virol.2006.11.023","article-title":"N-linked glycosylation of Gn (but not Gc) is important for Crimean Congo hemorrhagic fever virus glycoprotein localization and transport","volume":"361","author":"BR Erickson","year":"2007","journal-title":"Virology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.vaccine.2009.11.056","article-title":"Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines","volume":"28","author":"Z Wang","year":"2010","journal-title":"Vaccine"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.3201\/eid1012.040535","article-title":"Crimean-Congo hemorrhagic fever, Mauritania","volume":"10","author":"P Nabeth","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4269\/ajtmh.1987.36.120","article-title":"Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa","volume":"36","author":"R Swanepoel","year":"1987","journal-title":"Am J Trop Med Hyg"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"881","DOI":"10.7589\/0090-3558-39.4.881","article-title":"Experimental infection of white-tailed deer (Odocoileus virginianus) with Ehrlichia chaffeensis by different inoculation routes","volume":"39","author":"AS Varela","year":"2003","journal-title":"J Wildl Dis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1128\/JCM.34.9.2297-2299.1996","article-title":"Accelerated infectivity of tick-transmitted Lyme disease spirochetes to vector ticks","volume":"34","author":"CM Shih","year":"1996","journal-title":"J Clin Microbiol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1128\/IAI.00048-11","article-title":"Complementation of Rickettsia rickettsii RelA\/SpoT restores a nonlytic plaque phenotype","volume":"79","author":"TR Clark","year":"2011","journal-title":"Infect Immun"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ijid.2008.08.027","article-title":"Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever","volume":"13","author":"E Akinci","year":"2009","journal-title":"Int J Infect Dis"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jinf.2009.07.011","article-title":"Lymphocyte subgroups in children with CCHF: a marker for prognosis","volume":"59","author":"H Tezer","year":"2009","journal-title":"J Infect"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-1759(01)00397-0","article-title":"A simple and efficient method for the monitoring of antigen-specific T cell responses using peptide pool arrays in a modified ELISpot assay","volume":"254","author":"TW Tobery","year":"2001","journal-title":"J Immunol Methods"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jviromet.2011.11.020","article-title":"Development of an indirect ELISA method for the parallel measurement of IgG and IgM antibodies against Crimean-Congo haemorrhagic fever (CCHF) virus using recombinant nucleoprotein as antigen","volume":"179","author":"SD Dowall","year":"2012","journal-title":"J Virol Methods"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jcv.2005.02.016","article-title":"Evaluation of a Crimean-Congo hemorrhagic fever virus recombinant antigen expressed by Semliki Forest suicide virus for IgM and IgG antibody detection in human and animal sera collected in Iran","volume":"35","author":"S Garcia","year":"2006","journal-title":"J Clin Virol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.ijid.2011.06.005","article-title":"Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions","volume":"16","author":"B Ozturk","year":"2012","journal-title":"Int J Infect Dis"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1128\/CVI.00530-09","article-title":"Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever","volume":"17","author":"A Saksida","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3201\/eid1311.070222","article-title":"Viral load as predictor of Crimean-Congo hemorrhagic fever outcome","volume":"13","author":"D Duh","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1089\/vbz.2011.0776","article-title":"Review of Crimean Congo hemorrhagic fever infection in Kosova in 2008 and 2009: prolonged viremias and virus detected in urine by PCR","volume":"12","author":"S Thomas","year":"2012","journal-title":"Vector Borne Zoonotic Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0091516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T21:23:39Z","timestamp":1648589019000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0091516"}},"subtitle":[],"editor":[{"given":"James P.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,12]]},"references-count":67,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0091516","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,12]]}}}